Cargando…

Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study

Objective To determine whether use of cannabis in adolescence increases the risk for psychotic outcomes by affecting the incidence and persistence of subclinical expression of psychosis in the general population (that is, expression of psychosis below the level required for a clinical diagnosis). De...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuepper, Rebecca, van Os, Jim, Lieb, Roselind, Wittchen, Hans-Ulrich, Höfler, Michael, Henquet, Cécile
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047001/ https://www.ncbi.nlm.nih.gov/pubmed/21363868 http://dx.doi.org/10.1136/bmj.d738

Ejemplares similares

Exposure to environmental factors increases connectivity between symptom domains in the psychopathology network
por: Guloksuz, Sinan, et al.
Publicado: (2016)

Associations of familial risk factors with social fears and social phobia: evidence for the continuum hypothesis in social anxiety disorder?
por: Knappe, Susanne, et al.
Publicado: (2008)

T110. FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS
por: Quattrone, Diego, et al.
Publicado: (2018)

Social Defeat, Psychotic Symptoms, and Crime in Young Caribbean Immigrants to Rotterdam
por: Vinkers, David J., et al.
Publicado: (2021)

Salience attribution and its relationship to cannabis-induced psychotic symptoms
por: Bloomfield, M. A. P., et al.
Publicado: (2016)

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
por: Wiedmann, Melina, et al.
Publicado: (2022)

Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: (18)F-Fallypride Positron Emission Tomography Study
por: Kuepper, Rebecca, et al.
Publicado: (2013)

Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis
por: Radhakrishnan, Rajiv, et al.
Publicado: (2023)

O10.2. PSYCHOTIC EXPERIENCES ARE ASSOCIATED WITH HEALTH ANXIETY AND FUNCTIONAL SOMATIC SYMPTOMS IN PRE-ADOLESCENCE
por: Rimvall, Martin K, et al.
Publicado: (2018)

French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms
por: Favrod, Jerome, et al.
Publicado: (2012)

Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
por: Schoeler, Tabea, et al.
Publicado: (2022)

Incidence and persistence of psychotic experiences among young people
por: Staines, L, et al.
Publicado: (2023)

Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association—The Example of Cannabis and Psychosis
por: van Os, Jim, et al.
Publicado: (2021)

Physical diseases among persons with obsessive compulsive symptoms and disorder: a general population study
por: Witthauer, Cornelia, et al.
Publicado: (2014)

Differences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Population
por: Moriyama, Tais Silveira, et al.
Publicado: (2019)

Persistent psychotic symptoms following COVID-19 infection
por: Lim, Soon Tjin, et al.
Publicado: (2020)

Data Gathering Bias: Trait Vulnerability to Psychotic Symptoms?
por: Catalan, Ana, et al.
Publicado: (2015)

A 6-year follow-up study in a community-based population: Is neighbourhood-level social capital associated with the risk of emergence and persistence of psychotic experiences and transition to psychotic disorder?
por: Ergül, Ceylan, et al.
Publicado: (2023)

O2.2. CHILDHOOD ADVERSITIES AND PSYCHOTIC SYMPTOMS: THE POTENTIAL MEDIATING OR MODERATING ROLE OF NEUROCOGNITION AND SOCIAL COGNITION
por: Mansueto, Giovanni, et al.
Publicado: (2018)

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
por: Di Forti, Marta, et al.
Publicado: (2019)

Psychotic Cannabis Withdrawal: A Clinical Case
por: Ramos, Berta, et al.
Publicado: (2022)

Adversity, cannabis use and psychotic experiences: evidence of cumulative and synergistic effects
por: Morgan, Craig, et al.
Publicado: (2014)

Correction: Data Gathering Bias: Trait Vulnerability to Psychotic Symptoms?
por: Catalan, Ana, et al.
Publicado: (2015)

The jumping to conclusions reasoning bias as a cognitive factor contributing to psychosis progression and persistence: findings from NEMESIS-2
por: Rauschenberg, Christian, et al.
Publicado: (2021)

The Association between Negative Symptoms, Psychotic Experiences and Later Schizophrenia: A Population-Based Longitudinal Study
por: Werbeloff, Nomi, et al.
Publicado: (2015)

F33. MATERNAL AND PATERNAL CANNABIS USE DURING PREGNANCY AND RISK OF PSYCHOTIC SYMPTOMS IN THE OFFSPRING
por: Bolhuis, Koen, et al.
Publicado: (2018)

Using dimensionality-reduction techniques to understand the organization of psychotic symptoms in persistent psychotic illness and first episode psychosis
por: Fleming, Leah M., et al.
Publicado: (2023)

Cognitive impairment in first psychotic episodes: The role of cannabis
por: Boi, S., et al.
Publicado: (2021)

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls
por: Lawn, Will, et al.
Publicado: (2022)

Transdiagnostic symptom networks in relation to mental health service use in community youth
por: Imperiale, Marina N., et al.
Publicado: (2022)

Incidence and Persistence of Psychotic Experiences in the General Population: Systematic Review and Meta-Analysis
por: Staines, Lorna, et al.
Publicado: (2023)

From Epidemiology to Daily Life: Linking Daily Life Stress Reactivity to Persistence of Psychotic Experiences in a Longitudinal General Population Study
por: Collip, Dina, et al.
Publicado: (2013)

Psychotic symptoms in acromegaly
por: Pinto, Denzil, et al.
Publicado: (2005)

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study
por: Jongsma, Hannah E., et al.
Publicado: (2017)

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History
por: González-Pinto, Ana, et al.
Publicado: (2016)

Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences
por: Jones, Hannah J., et al.
Publicado: (2018)

The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
por: Elias De Sousa, A., et al.
Publicado: (2022)

Avatar Intervention for cannabis use disorder in patients with psychotic and mood disorders
por: Giguère, S., et al.
Publicado: (2023)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
por: Bartoli, Francesco, et al.
Publicado: (2021)

Do Anxiety Symptoms Mediate the Association Between Cannabis Use Frequency and Psychotic-Like Experiences in Emerging Adult Undergraduates?
por: Bernusky, Haley C. R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fa3c6a8c574jacpramq636no99